Hyunsun Jo
Founder, CEO Pin Therapeutics
Founder and Chief Executive Officer of Pin Therapeutics, Korea (2017-)
Founding Partner of Embedbio (The Early-Stage Investment Company Builder Specialized in Biotech and Healthcare Sectors), Palo Alto, CA, USA
Postdoctoral Fellow of Medicine, J David Gladstone Institute (UCSF), CA, USA
PhD of Biological Sciences, Seoul National University (Metabolic Diseases), Korea
Bachelor of Chemistry, Seoul National University, Korea
Bachelor of Biological Sciences, Seoul National University, Korea
Seminars
Thursday 30th October 2025
Harnessing a Novel E3 Ligase-Targeting DAC to Overcome Hematologic Toxicity in ADCs
1:30 pm
- Engineering a degrader payload that recruits a novel E3 ligase to enable selective degradation of tumor-driving proteins with reduced hematologic offtarget effects
- Advancing beyond traditional cytotoxic payloads by leveraging targeted protein degradation to minimize collateral damage to healthy blood cell lineages
- Unlocking a new class of safer, next-gen DACs with differentiated biological mechanisms to improve therapeutic index across hematologic indications
